QUANTI-HLAb: An In Vitro Diagnostic Kit for transplant recipients

APPLICATIONS

• Diagnostic kit for organ transplantation
• Identification of HLA antibodies parameters
• Evaluation of HLA antibodies pathogenicity
• Prevention of transplant rejection
• Follow-up of humoral rejection therapies

DESCRIPTION

• Innovative technology based on Surface Plasmon Resonance (SPR) in a capture mode,
• Access to HLA antibodies’ active concentration and affinity,
• Active concentration (high capture level) and affinity (low capture level) of several sample/HLA targets can be performed on the same chip.

BENEFITS

• Determination of quantitative parameters for HLA antibodies in patient samples
• No calibration curve and reusable chip
• Real-time and label-free assay
• To anticipate clinical outcomes for organ recipients
• To facilitate clinical decision

IP

This technology is protected by a patent application

MATURATION

Proof of concept established on a cohort of lung transplant recipients